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Abstract
Non-long terminal repeat (non-LTR) retrotransposons are present in most eukaryotic genomes. In some species, such 
as humans, these elements are the most abundant genome sequence and continue to replicate to this day, creating a 
source of endogenous mutations and potential genotoxic stress. This review will provide a general outline of the 
replicative cycle of non-LTR retrotransposons. Recent findings regarding the host regulation of non-LTR 
retrotransposons will be summarized. Finally, future directions of interest will be discussed.
Introduction
The biological drive to replicate makes it almost inevita-
ble that selfish genetic elements will populate genomes
[1]. Indeed, genome sequencing has revealed that single
copy genes are often vastly outnumbered by repetitive
transposable elements [2-6]. The abundance and distri-
bution of any particular transposon depends on how
aggressive the transposon is (how quickly it can multiply
in copy number), where the transposon inserts new cop-
ies, and how the host responds. Since these factors can
vary greatly, the transposon content of each species is
unique and virtually impossible to predict a priori. In
humans, this number is at least 45% [2].
Transposons can be divided into two broad classes:
DNA transposons and retrotransposons. DNA transpo-
sons replicate via a cut and paste mechanism [7], whereas
retrotransposons replicate using an RNA intermediate.
Retrotransposons can be further subdivided into long ter-
minal repeat (LTR) and non-LTR retrotransposons. LTR
retrotransposons are retroviral-like in structure and
mechanism [8]. Non-LTR retrotransposons (also called
LINEs, polyA retrotransposons, or target-primed (TP)
retrotransposons), as implied by their name, do not con-
tain LTRs and instead take on the likeness of an inte-
grated mRNA. They are ancient genetic elements that
have persisted in eukaryotic genomes for hundreds of
millions of years [9], and are perhaps best known for their
enormous success multiplying in the human genome.
Although non-LTR retrotransposons can be parasitized
by non-autonomous elements (for example, short inter-
spersed transposable elements (SINEs)), this review will
focus on autonomous elements, which encode the pro-
tein machinery necessary for their self-mobilization.
Non-LTR retrotransposons: general structure
Full length, autonomous non-LTR retrotransposons typi-
cally contain one or two open reading frames (ORFs). The
general structure of three model examples, the Bombyx
mori R2 element, the human L1 element, and the Droso-
phila melanogaster I factor, are depicted in Figure 1. Cen-
tral to retrotransposon mobilization is reverse
transcriptase (RT) activity, and thus all autonomous non-
LTR retrotransposons contain an RT domain. Also pres-
ent in virtually all non-LTR retrotransposons is an endo-
nuclease (endo) domain [10-12], although encoded endo
activity is not an absolute requirement for non-LTR ret-
rotransposition (see Mechanisms below). A second ORF
(ORF1) appears to have been an early evolutionary addi-
tion [12]. ORF1 contains RNA binding activity [13-15]
and nucleic acid chaperone activity [16], and may play a
similar role to the gag proteins of retroviruses.
The 5' and 3' untranslated regions (UTRs) of non-LTR
retrotransposons are quite variable. Although most char-
acterized 5' UTRs of functional non-LTR retrotranspo-
sons contain internal promoter activity [17-25], promoter
replacement is frequent [26,27] and therefore promoter
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sequence is not necessarily conserved among elements
from different species. Evidence suggests that these pro-
moters are transcribed by RNA polymerase II. There are
also elements with no apparent endogenous promoter.
For example, the R2 elements, which are found in insect
ribosomal DNA loci, do not appear to encode their own
promoter, and are thought to be cotranscribed with their
host rRNA repeat [28]. The 3' UTR of non-LTR elements
usually contains a specific sequence/structure that is rec-
ognized by the reverse transcriptase ORF [29-32]. A
notable exception is the mammalian L1 element, for
which the 3' UTR is dispensable for retrotransposition
[33]. The 3' boundary of non-LTR retrotransposons can
consist of polydeoxyadenosine (polyA) sequence, short
sequence repeats [30,34], or neither. Because of the wide
variability in the UTRs of non-LTR retrotransposons, we
hesitate to make sweeping generalizations on specific
details of non-LTR transcription initiation and termina-
tion. Although Figure 1 shows full-length elements, non-
LTR retrotransposons in genomes are often 5' truncated
due to incomplete reverse transcription [35]. Only a sub-
set of elements are full length and active; for example, out
of 500,000 L1s in the human genome, only approximately
7,000 are full length, and of those only 80 to 100 are esti-
mated to be active for retrotranposition [36].
Non-LTR retrotransposon replication mechanisms
Outline of life cycle
A general outline of non-LTR retrotransposon replication
is shown in Figure 2a. Following transcription and
nuclear export, the ORF(s) are translated and assemble to
form a ribonucleoprotein particle (RNP) [37-39]. For pol
II transcribed elements, the first ORF is most likely trans-
lated by the traditional cap recognition and scanning
model. This mode of translation (as opposed to an inter-
nal ribosomal entry site (IRES)) is supported by experi-
ments in mammals demonstrating that the 5' UTR, 3'
UTR, and interORF sequence of L1 are dispensable for
retrotransposition ([33]; JSH and Jef Boeke, Johns Hop-
kins University, unpublished results), the coding region of
ORF1 can be extensively mutated without compromising
retrotransposition [40], and that translation initiated
from the human L1 5' UTR is cap dependent [41]. Ele-
ments transcribed by pol I, such as the R1/R2 elements,
may be translated via an IRES [28], although this awaits
experimental confirmation. In bicistronic transcripts,
translation of the second ORF2 relies upon unconven-
tional translation initiation. Studies with the silkworm
SART1 element and human L1 element suggest similar
translation mechanisms, where ORF2 translation is
dependent on ORF1 translation [42,43]. The ribosome
that translated ORF1 may reinitiate translation at ORF2,
or may recruit another ribosome to serve this purpose.
Using ORF1 as a marker, non-LTR retrotransposon
RNPs in most cases are localized predominantly in the
cytoplasm [37,39,44-51]. An interesting exception has
been reported in rat, where endogenous rat L1 ORF1 pro-
tein is concentrated in the nucleus in a chronic myeloid
leukemia (CML) cell line [52]. The reason for this anoma-
lous expression pattern is unclear, although one plausible
explanation is the production of a mutated version of
ORF1 in this particular cell line that escapes cytoplasmic
retention [50,52]. Furthermore, a cloned, retrotransposi-
tionally competent rat L1 produced predominantly cyto-
plasmic RNPs when localized in other cell lines [52].
Other notable examples of nuclear non-LTR retrotrans-
poson RNPs are the telomere targeted elements, which
are likely beneficial to the cell [53,54].
Closer examination of non-LTR retrotransposon RNPs
in mammals has revealed localization to stress granules,
cytoplasmic bodies closely associated with P bodies [50].
Stress granules have been described as a repository for
non-translating mRNAs [55]. It is not clear whether
stress granule-associated non-LTR RNPs are destined for
destruction, or whether transit through the stress granule
is an important step in the maturation of a retrotranspo-
Figure 1 Structure of non-long terminal repeat (non-LTR) ret-
rotransposons. The general structures of three model non-LTR ele-
ments are shown. Top: the Bombyx mori R2 element consists of a single 
open reading frame (ORF) containing reverse transcriptase (RT) activity 
and a restriction enzyme-like (REL) domain. Vertical lines indicate 
cysteine-histidine rich regions believed to encode nucleic acid binding 
domains. Horizontal lines are untranslated regions. Middle: the human 
L1 element contains two ORFs. ORF1 contains a leucine zipper (LZ) do-
main involved in protein-protein interactions and a C-terminal nucleic 
acid binding domain (BD). ORF2 has a N-terminal apurinic/apyrimidin-
ic endonuclease (APE), a central RT domain, and a C-terminal cysteine-
histidine rich domain. The element ends with a polyA tail. Typical inser-
tions are flanked by target site duplications (bold arrows). Bottom: the 
Drosophila I factor element. ORF1 contains three C-terminal cysteine-
histidine rich motifs resembling those of retroviral gag. ORF2 contains 
an APE endonuclease, central RT/RNaseH (RNH) domain, and C-termi-
nal cysteine-histidine domain. In all structures contiguous gray boxes 
represent a single ORF.
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son RNP . However, it is noteworthy that loss of P body
components in yeast lead to a decrease in Ty1 and Ty3
(LTR retrotransposons) activity, suggesting an important
role of P bodies and/or stress granules in the life cycle of
retrotransposons [56-60]. The dynamics of non-LTR ret-
rotransposon RNPs have been studied most dramatically
with the Drosophila I factor [39,47]. I factor RNPs appear
in nurse cells then are translocated to the oocyte cyto-
plasm along with other nurse cell components. In the
oocyte, the RNPs migrate from the posterior to anterior
cortex, following the microtubule organizing center and
the nucleus [39,47]. I factor RNP migration is reminiscent
of  bicoid  mRNA/Staufen protein RNP transport
[47,61,62]. The microtubule dependence of this process
suggests that non-LTR RNPs may also track along the
cytoskeleton. There are also hints that L1 ORF1 protein
interacts with intermediate filaments, further bolstering
this hypothesis [52]. At some point, a non-LTR ret-
rotransposon RNP must have access to a chromosome,
and therefore is presumably transported into the nucleus
[63,64], where reverse transcription occurs.
Target-primed reverse transcription
Once at a suitable chromosomal target site, a non-LTR
retrotransposon can begin to copy its genetic information
at this new locus. The mechanism for this process has
been termed target-primed reverse transcription (TPRT)
and the initial stages have been demonstrated most con-
vincingly with in vitro studies of the Bombyx mori R2 ele-
ment. Purified R2 protein, when mixed with R2 RNA and
a suitable DNA target site, is able to nick the DNA on one
strand (the bottom strand in Figure 2b). The resulting
free 3' DNA end serves as a primer to reverse transcribe
the R2 RNA (minus strand synthesis). A similar system
using human L1 ORF2 has also provided evidence for this
reaction, although products could not be monitored
directly due to their low yield and non-uniformity (L1
Figure 2 Replication of non-long terminal repeat (non-LTR) retrotransposons. (a) Replicative cycle of non-LTR retrotransposition. (i) Transcrip-
tion of a full-length, active element. (ii) mRNA export from the nucleus. (iii) Translation of retrotransposon proteins and (iv) passage through cytoplas-
mic granule. (v) Ribonucleoprotein particle (RNP) import into the nucleus. (vi) Integration via target-primed reverse transcription (TPRT). (b) A model 
for TPRT. (i) Original unmodified target site. This sequence at this site will vary depending on the specificity of the retrotransposon endonuclease. (ii) 
Cleavage of one strand of the target site (bottom strand in the figure) by endonuclease. (iii) Minus strand synthesis using retrotransposon mRNA as a 
template. (iv) During or after minus strand synthesis, top strand cleavage occurs by the retrotransposon endonuclease or a cellular endonuclease. A 
downstream cleavage (left pathway) leads to a target site duplication (TSD). An upstream cleavage (right pathway) leads to a target site deletion. (v) 
Template jump from mRNA to top strand of target site. (vi) Plus strand synthesis using the cleaved top strand as primer. (vii) Left pathway: complete 
of synthesis and fill in of gaps (blue) leads to a target site duplication. Right pathway: completion of synthesis and degradation of non-homologous 
flaps by unknown nucleases leads to a target site deletion (purple sequences). There are alternative products that are not shown in this model for 
simplicity.
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ORF2, unlike the R2 ORF, does not nick a rigidly defined
target DNA). The target site of non-LTR retrotranspo-
sons is dictated by the encoded endonuclease domain.
Ancient non-LTR clades, such as CRE, R2, and R4,
encode restriction enzyme-like endonucleases [12] that
recognize specific sequences. This endo domain was
replaced by an abasic endonuclease early in non-LTR
evolution [12], leading in most cases to relaxed target site
specificity. The importance of the endonuclease domain
lies in producing a primer for reverse transcription. If a
suitable primer can be created via another mechanism,
non-LTR retrotransposition can proceed in an endo-
independent manner [65]. Perhaps the most dramatic
example of endo-independent non-LTR retrotransposi-
tion occurs naturally in Drosophila, where the codepen-
dent non-LTR retrotransposons TART, HeT-A and
TAHRE retrotranspose at chromosome ends to form the
telomeres [54,66-68]. A similar reaction has been recapit-
ulated on mammalian chromosome ends with an engi-
neered endo mutant human L1 [69], suggesting the
possibility of a 'pre-endo' era of non-LTR retrotranspo-
sons that extended and/or repaired free DNA ends.
The remaining steps of non-LTR integration remain
somewhat murky but are hypothesized to occur as fol-
lows (see Figure 2b). After or during minus strand syn-
thesis, a second strand nick of the target site occurs (on
the top strand of Figure 2b). Depending on the specific
non-LTR retrotransposon involved, the second strand
nick can occur downstream, upstream, or in line with the
bottom strand nick to generate target site duplications
(TSDs), target site deletions, or blunt insertions. The
non-LTR endo domain is presumed although not proven
to also make this second nick, and evidence suggests that
at least one non-LTR RT/endo ORF works as a dimer,
with each subunit catalyzing one of the nicks [70,71].
How the position of the second strand nick is selected is
not entirely clear and probably differs between different
elements. In some cases, the second strand nick is likely
predefined by the retrotransposon endo domain. For
mammalian elements, there is some evidence that micro-
homology to the newly synthesized bottom strand dic-
tates second strand cleavage [72,73]. In most cases,
however, we simply do not know how the second strand
cleavage occurs.
Second strand cleavage creates a primer for plus strand
synthesis. The newly synthesized minus strand jumps
templates from the retrotransposon RNA to the target
s i t e  D N A  t o p  s t r a n d .  T h is  s t r a n d  e x c h a n g e  is  pos s i b l y
facilitated by the addition of non-templated nucleotides
[74] and/or the assistance of the ORF1 nucleic acid chap-
erone activity [16]. Plus strand synthesis proceeds from
the second nick. Some non-LTR clades have acquired an
RNase H domain, which likely removes mRNA template
as minus strand synthesis occurs [12,75]. Others have no
evidence of an RNase H domain, and the mRNA may
simply be displaced by second strand synthesis [76]. In
the case of a downstream second strand nick, gaps are
filled in to produce TSDs (Figure 2b, left pathway). In the
case of an upstream second strand nick (Figure 2b, right
pathway), non-homologous flaps are removed by
unknown factors to generate target site deletions. After
DNA synthesis is complete, the remaining nicks are
ligated to complete the insertion.
Host-encoded factors facilitating non-LTR retrotransposons
It is generally believed that host-encoded factors are
required for a complete integration (TPRT) reaction [77].
There are multiple reasons for this line of thought. No
non-LTR retrotransposon has ever been shown (bio-
chemically or bioinformatically) to encode proteins with
a l l  t h e  e x p e c t e d  a b i l i t i e s  r e q u i r e d  t o  c o m p l e t e  s u c h  a
reaction. For example, the nicks generated by TPRT need
to be sealed after DNA synthesis, and encoded ligase
activity has not been found within non-LTR elements. In
the case of target site deletions, unidentified nucleases
eliminate unpaired DNA (Figure 2b, vii, right pathway).
In addition, the complete retrotransposition event has
never been recapitulated in vitro with purified substrate
and non-LTR proteins. This of course could simply be
due to the complex multistep nature of non-LTR integra-
tion and our inability to find the appropriate test tube
conditions. However, sequence analysis of genomic inte-
gration events suggests the involvement of host DNA
repair machinery in some instances of non-LTR integra-
tion [72,78]. Finally, experimental data suggests a depen-
dence of non-LTR retrotransposons on host DNA repair
pathways. Transfection of a human L1 plasmid into mam-
malian cells leads to the generation of endodependent
DNA double strand breaks (DSBs), and successful L1 ret-
rotransposition in this tissue culture system depends on
the ATM kinase involved in homologous recombination
and non-homologous end joining (NHEJ) [79]. More
recently, cells deficient in the NHEJ factors Ku70,
Artemis, and LigIV showed partial inhibition of ret-
rotransposition product formation [80]. Similar studies of
the  Lactococcus lactis L1.LtrB group II intron have
revealed multiple Escherichia coli DNA repair factors
required for intron retrohoming [81]. These bacterial
introns share a common ancestry with non-LTR ret-
rotransposons and thus are highly relevant to under-
standing non-LTR mechanisms [9]. Overall, these data
implicate host factors in the resolution of TPRT; however,
the limitations of the assays used allow alternative expla-
nations (see Lingering questions below). Non-LTR ret-
rotransposons are not unique in this regard, as other
transposon classes also require host factors for resolution
of transposition intermediates and/or repair of the donor
site.Han Mobile DNA 2010, 1:15
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Host regulatory mechanisms limiting non-LTR 
retrotransposons
From the perspective of a transposon, it makes sense to
be most active in the germ line or sexual phase of the host
organism's life cycle; after all, these are the cells that will
give rise to the next generation. In contrast, transposition
events in somatic cells will be evolutionarily non-produc-
tive, since those new transposition events are lost when
the host organism dies. As would be predicted, non-LTR
retrotransposons are expressed and retrotranspose in
germ cells [45-47,82]. While transposon 'success' depends
on transposition in the germ line, the genomic insult of
excess transposition can have negative effects on the host.
Therefore, host cells generally repress transposon activ-
ity. This implies that germ cells are a major evolutionary
battleground between transposons and the host, where
loss of transposon repression can have dramatic conse-
quences. For example, hybrid dysgenesis is a long known
phenomenon in Drosophila where the progeny of trans-
poson-naïve females and active transposon-containing
males are subject to a range of syndromes including
mutation, chromosomal rearrangements, and sterility
[83,84]. This syndrome is due to the host's inability to
control transposon activity. More recently, the devastat-
ing effect of unleashing excess transposition in the mam-
malian germ line has become apparent, where
upregulation of L1 and IAP elements are postulated to
lead to sterility [85-88].
Small RNA pathways
The discovery of RNA interference (RNAi) [89] led to the
hypothesis that small RNAs are involved in silencing
transposons via DNA methylation and degradation of
transposon RNA. Forward genetic screens revealed that
RNAi mutants can indeed lead to general transposon
derepression [90,91]. We now know that cells express var-
ious classes of small RNAs: microRNAs (miRNAs),
endogenous small interfering RNAs (endo-siRNAs), and
Piwi interacting RNAs (piRNAs) are among the most
studied. A significant fraction of endo-siRNAs and piR-
NAs correspond to transposon sequence, implying a
sequence-based recognition and repression mechanism
[92-107]. These RNAs interact with Argonaute protein
family members in order to carry out their regulatory
functions [108]. piRNAs are germ cell specific, while
endo-siRNAs are ubiquitous.
A model for piRNA-mediated silencing of transposons
in the germ line has emerged from elegant experiments in
Drosophila and mice. In this model, two classes of piR-
NAs associate with different Argonaute family members.
A class of piRNAs corresponding to the sense orientation
of transposon transcripts associates with Piwi and Ago3
(MILI in mice) [85,94], and a class of piRNAs antisense
with respect to transposon mRNA associates with Auber-
gine (MILI2 in mice) [94,109]. These classes of piRNAs
are amplified by a 'ping-pong' mechanism whereby the
sense strand piRNA directs cleavage and formation of an
antisense strand, and vice versa [94]. The origin of the
antisense piRNAs, in many cases, can be traced to long
piRNA precursors transcribed from a small number of
discrete piRNA clusters in the genome [94], some of
which are already known to be 'master regulators' of
transposon control [110-116].
Mutation of endo-siRNA and piRNA Argonaute part-
ners leads to transposon upregulation [85-87,117-119].
T r a n s p o s o n  u p r e g u l a t i o n  i s  a s s o c i a t e d  w i t h  d e f e c t s  i n
germ cell development, emphasizing the importance of
transposon silencing [86-88]. In germ cells, ping-pong
amplification is presumed to not only cleave transposon
mRNA leading to post-transcriptional repression, but
also serves to generate sequence-specific substrates to
guide DNA methylation. It is well known that transpo-
sons are associated with DNA methylation, and this
methylation plays an important role in long-term trans-
poson silencing [120,121]. Mutations in MILI and MIWI2
lead not only to piRNA defects but also failure of proper
transposon DNA methylation, providing a genetic link
between piRNA production and the eventual methylation
of transposon DNA [87]. It is assumed that the piRNA
effector complexes somehow recruit the de novo DNA
methyltransferases DMNT3A, DMNT3B, and their asso-
ciated protein DMNT3L to methylate transposon loci.
How this is accomplished is not yet clear, and the molecu-
lar mechanisms underlying these processes are currently
an area of active investigation [122-124]. It is likely that
this process will resemble well studied pathways of het-
erochromatin formation in various organisms (reviewed
in [125,126]). We should also mention that these mecha-
nisms are not specific to non-LTR retrotransposons but
apply to all transposons.
Intracellular defense by the APOBEC protein family
The antiviral activity of the APOBEC3G cytidine deami-
nase was first recognized for its ability to inhibit the HIV
retrovirus [127,128]. APOBEC3G cytosine deamination
of the newly synthesized HIV cDNA strand results in G
to A hypermutation in the viral coding sequence. Since
retroelements synthesize a similar nascent cDNA strand,
this finding led to the hypothesis that APOBEC family
members similarly inhibit retrotransposons. Indeed, all
APOBEC3 family members have been shown to inhibit
retrotransposon activity [129-135] using a cell line-based
assay, although there are inconsistencies in the literature
as to whether APOBEC3G inhibits L1 elements. These
inconsistencies may be due to varying levels of endoge-
nous APOBEC3 proteins expressed in laboratory cell
lines [135]. In addition, the activation-induced deaminase
(AID) gene, which may share common ancestry with the
APOBEC3 proteins, also inhibits L1 in the same cell line-
based assay [136].Han Mobile DNA 2010, 1:15
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Surprisingly, hypermutation of the integrated ret-
rotransposition product does not occur upon APOBEC3
member coexpression with non-LTR retrotransposons,
and cytidine deaminase activity was shown to be dispens-
able for the antiretrotransposon effect in most but not all
cases (a separation of function of antiviral activity from
cytidine deaminase activity has also been shown for HIV
[137]). Thus, there are likely at least two distinct mecha-
nisms for non-LTR retrotransposon inhibition by
APOBEC family members: deaminase dependent and
deaminase independent. The lack of coding strand G to A
hypermutation in the deaminase-dependent mechanism
could be due to the quick degradation of nascent cDNA
minus strands containing uracil, preventing the resolu-
tion of deaminase-modified retrotransposition interme-
diates. The mechanism of deaminase-independent
APOBEC3 inhibition of non-LTR retrotransposons is
currently unclear, although localization of the specific
proteins may give clues to possible function. APOBEC3A,
B, C, and H, inhibitors of human L1, localize at least par-
tially to the nucleus [131,135], suggesting a possible func-
tion in blocking L1 integration. APOBEC3DE, F , and G
appear predominantly in the cytoplasm. They may serve
a role in cytoplasmic sequestration of RNPs, although a
fraction of these APOBECs may also shuttle to and per-
form a function in the nucleus [131]. Recently
APOBEC3G has been shown to localize to P granules and
stress granules [138]. Given the presence of L1 RNPs in
stress granules [50], APOBEC3G may sequester L1 in
these granules. Coexpression of ORF1 protein with Alu (a
non-autonomous non-LTR parasite of L1) shifts a frac-
tion of Alu transcripts from the nucleus to ORF1p-con-
taining stress granules [51]. Interestingly, APOBEC3G
also inhibits Alu elements [139,140], and the colocaliza-
tion of APOBEC3G, L1, and Alu suggest a common (but
poorly understood) mechanism.
It should be noted that APOBEC3 proteins have
recently been implicated in the clearance of foreign DNA
introduced into cultured cells, irrespective of whether the
foreign DNA encodes a transposable element [141]. This
restriction of foreign DNA also has both deaminase-
dependent and deaminase-independent pathways, and
perhaps casts some doubt on the specificity of APOBEC
retroelement control. However, these data are somewhat
at odds with controls performed in prior studies
[132,142]. Ultimately, definitive proof for biologically rel-
evant regulation of non-LTR retrotransposons by
APOBECs will likely require the demonstration of an
APOBEC3-related effect on endogenous retroelements in
an organism.
Lingering questions
There are still large gaps in our knowledge of non-LTR
retrotransposon biology. Here I will discuss open ques-
tions that I feel are of outstanding interest. Since we are
humans, and the non-LTR L1 element is that only known
autonomous transposon in the human genome, these
questions are framed in the context of mammalian L1
biology. However, some these questions can be addressed
in various model systems, as cell biology between species
is remarkably conserved.
What is the natural frequency of human retrotransposition?
'Back of an envelope' calculations have been used to esti-
mate that, among every 10 to 20 new humans born, there
is on average one new L1 retrotransposition event
[143,144]. These calculations were based on multiplying
the fraction of known human mutations caused by ret-
rotransposition by an estimated total mutation rate per
generation. Possible sources for error in these calcula-
tions are the underestimation of retrotransposition
events due to detection bias and the reliance on pheno-
types to find mutations, which only samples a subset of
genes and genomic regions. Human retrotransposition
frequency has also been estimated at 1 new insertion per
2 to 33 individuals, based on the summed retrotransposi-
tion frequency of tagged active L1s in a tissue culture or
transgenic mouse retrotransposition assay [33,36,145].
Although consistent with previous estimates, these assays
carry the caveat that they are performed in non-natural
environments for a human retrotransposons (somatic
cells and live mice). Current projects to catalog ret-
rotransposon polymorphisms in humans will provide
another way to estimate retrotransposition rates based on
allele frequencies. However, the advent of next generation
sequencing [146] and rapidly decreasing per base
sequencing costs should make it possible in the near
future to directly determine retrotransposition frequency
by sequencing and comparing the genomes of successive
family generations. This would not only give an average
frequency of retrotransposition, but would also be able to
highlight the potential wide variability of retrotransposi-
tion frequency between human individuals. This individ-
ual variability is due to variation of the number of 'hot'
(highly active) L1s in a particular genome, as well as
mutation of 'hot' L1s to give 'cool' alleles [147,148].
What pathways are at the LINE-host interfaces?
Previously, technical limitations have precluded laborato-
ries from performing large systematic screens for factors
that regulate LINEs. The studies leading to the recent
exciting findings that small RNAs and APOBECs inhibit
retroelements actually originated from non-retrotranspo-
son laboratories. However, these serendipitous findings
hint that careful examination will yield even more host
pathways that interact with L1-like elements. In the past
decade, the development of technology to knock down
mammalian gene expression with short interfering RNAs
[149] has made it possible to assess candidate gene con-
tributions to retrotransposition without the time con-Han Mobile DNA 2010, 1:15
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suming step of manipulating mammalian chromosomes.
This should allow the eventual screening of many, if not
all, mammalian genes for effects on retrotransposition in
standard tissue culture [33]. Simple yeast assays are also
now available for LINE retrotransposition [150,151]. The
fast and low cost methods of yeast genetics provide an
attractive complementary system to probe the non-LTR/
host interface.
Even with these technical advances, the limitations of
current retrotransposition assays must be kept in mind
when interpreting the results of a genetic screen. TPRT
by definition involves breakage of DNA strands, and is
therefore potentially genotoxic. The rate of L1 RNP for-
mation, DNA damage, and stress (virtually every cell
expressing active L1) far exceeds the rate of successful
retrotransposition in a typical human cell culture assay (1
in 20 to 1 in 10,000) [79,152-154]. Therefore, one can eas-
ily imagine that any mutation that modifies the ability to
tolerate DNA damage or stress will alter the apparent ret-
rotransposition frequency, even if the true retrotranspo-
sition frequency remains unchanged. The
retrotransposition assays are also not yet adapted for
genetic screens in the natural L1 environment (germ
cells). Although screens in embryonic stem cells [155] or
sporulating yeast may come closer to approximating the
natural context of LINE retrotransposition, the germ cell
environment is quite unique and may contain non-
somatic processes that stimulate or inhibit retrotranspo-
sition. Finally, unraveling the contribution of potential
'hits' to retrotransposition will be a daunting task, as the
assay gives no indication as to what step in the poorly
understand L1 life cycle is affected, and we still do not
have a way to directly monitor which cells are undergoing
active retrotransposition. This is perhaps not such a bad
thing, as it will keep us occupied for years to come.
Localization of L1 proteins: what are we really looking at?
The vast excess of L1-containing cytoplasmic granules as
compared to the actual number of successful retrotrans-
position events leads us to our next question. If TPRT
occurs in the nucleus, why are RNPs overwhelmingly in
the cytoplasm? Are we simply looking at non-functionally
relevant, retrotransposon trash? An answer to this ques-
tion is suggested by looking at the distribution of non-
LTR retrotransposon RNPs in Drosophila. Drosophila has
20 families of non-LTR retrotransposons [156]. Rashkova
et al. examined the location of five non-LTR element
ORF1s, which presumably track with RNPs [48]. The Het-
A and TART elements, which retrotranspose onto chro-
mosome ends to form telomeres, are believed to perform
an important cellular function for the host since Droso-
phila lacks telomerase enzyme. The RNPs for Het-A and
TART were found to be efficiently transported into the
nucleus. In contrast, RNPs for the euchromatic-targeted
non-LTR retrotransposons jockey, doc, and I factor were
predominantly sequestered in the cytoplasm. Thus it
seems that host cells have a surveillance system that is
able to distinguish 'friendly' from 'unfriendly' RNPs, and
target only the latter for inhibition. It remains an open
question whether these sequestered RNPs are still active
and ready for retrotransposition, or marked for certain
death. Is retrotransposition the result of a lucky RNP that
escapes the stress granule, or is there an as of yet unde-
tected 'true' retrotransposition pathway that bypasses
these granules altogether? Is there a rare activating signal
that can induce retrotransposition? Genetics, improve-
ments in retrotransposition frequency, and the develop-
ment of sensitive tools to visualize RNP transport and
action in the nucleus will go a long way towards answer-
ing these questions.
Do we need retrotransposon activity?
A glance through genomes of higher eukaryotes will show
something akin to 'genes floating on a sea of retrotrans-
posons' [157]. How can these repeated sequences multi-
ply to such high numbers if they do not provide some
function for the host? A common mistake is to think of
transposons as being under typical Mendelian con-
straints. This is not the case. Transposons can replicate
and increase in number at a rate faster than single copy
genes in the genome. In principle, an aggressively repli-
cating transposon can rapidly sweep through a sexual
population without conferring any fitness benefit [158].
The increase of transposon presence with each successive
generation must simply outweigh any negative fitness
effects.
Even if not conferring a net fitness benefit, transposons
provide a source of endogenous mutation. Rather than
simple point mutations, deletions and rearrangements,
transposon mutations have the advantage of dispersing
prebuilt functional units, such as transcription regulatory
sequences, protein-binding DNA, and open reading
frames encoding nucleic acid binding, cleavage, and syn-
thesis activities. Thus, it is not surprising that after mil-
lions of years of evolution some of the many transposon
bits and pieces littered among genomes have been put to
use by the host cell. For example, genome rearrangements
such as V(D)J recombination and programmed DNA
deletion in ciliates are performed by proteins that share
ancestry with transposases [159,160]. Retrotransposon
sequences have also been incorporated into the coding
sequence of many human proteins [161]. In addition, the
silencing of retrotransposons can lead to epigenetic
effects on adjacent genes [162]. The abundance of L1 ele-
ments on the X chromosome has even led to the theory
that retrotransposons are involved in X inactivation
spreading [163]. It is important, however, to note that
host utilization of transposon remnants does not necessi-
tate or even imply that active (retro)transposition is an
important functional component of host cell biology. TheHan Mobile DNA 2010, 1:15
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only case of probable host requirement for retrotranspo-
son activity that I am aware of is the aforementioned
telomere maintenance of some insects, which is per-
formed by non-LTR retrotransposons. Overall evidence
suggests that transposons do not 'come in peace', and
only after host adaptation are they subdued and in rare
cases turned from the 'dark side'. Nevertheless, the pres-
ence of at least one case of a 'good' retrotransposon hints
that there may be other interesting examples of symbiotic
active retrotransposons awaiting discovery.
Conclusions
The past 20 years has seen remarkable progress in our
knowledge of non-LTR retrotransposon biology. Non-
LTR retrotransposons are major components of eukary-
otic genomes and our cells have evolved elaborate mecha-
nisms to deal with these selfish elements. Since the L1 is
the only active autonomous transposon in humans, and
has directly or indirectly produced over one-third of our
genome sequence, non-LTR retrotransposon biology is
particularly important for understanding human genome
evolution. The genotoxic effects of retrotransposons in
mice and tissue culture also suggest that further investi-
gation into the mechanisms of non-LTR retrotransposi-
tion will allow us to manipulate retrotransposon activity
to confer potential health benefits. Finally, insight into
host -r et r ot ra ns poso n in t e r act io ns wil l give  us a  c lea r e r
picture on how cells recognize and silence DNA repeats;
a question relevant to all of biology.
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